What Are the Evolving Opportunities for the Players in the Molecular Biology Kits & Reagents and Enzymes Market?
The prevalence of cancer across the world is rising at a significant rate. According to the World Health Organization, cancer is the second leading cause of death worldwide, and was responsible for about 9.6 million deaths in 2018. Cancer basically arises from the transformation of normal cells into tumor cells, which is a multistage process and usually progresses from a pre-cancerous lesion to a malignant tumor. Some of the major risk factors for cancer include alcohol usage, tobacco consumption, physical inactivity, and an unhealthy diet. If diagnosed early, cancer can be dealt with getting proper treatment and palliative care.
However, researchers are still striving to find a definitive cure for cancer, which could further aid in reducing the burden of the disease. Attributed to this, the demand for molecular biology kits & reagents and & enzymes is growing swiftly. These products are utilized for performing ribonucleic acid (RNA) analysis, deoxyribonucleic acid (DNA) isolation, cloning, polymerase chain reaction, DNA sequencing, RNA extraction, and protein analysis. They are also used for performing several diagnostic tests, genetic analysis, molecular tests, and aid in drug discovery and development. Associated with the field of biochemistry, biology, and genetics, molecular biology products allow scientists to understand the cellular systems in a better and simplified manner.
Because of these factors, the molecular biology kits & reagents and enzymes market is expected to register substantial growth in the coming years. Apart from cancer, these products are also being utilized within the protocol for diagnosing patients who are suffering from diabetes and infections. DNA extraction process takes place with the help of molecular biology products, which is the initial step for the diagnosis of diseases and genetic disorders, including Alzheimer’s disease, sickle cell anemia, and cystic fibrosis. The techniques which are used for extracting DNA are terminal restriction fragment length polymorphism, fluorescence in situ hybridization, and sequencing.
The surging prevalence of infectious diseases is also leading to the rising demand for these products across the globe. The incidence of diseases such as hepatitis C virus, human immunodeficiency virus (HIV), healthcare associated infections, and human papilloma virus is growing due to poor lifestyle and lack of access to preventive care. As per the Joint United Nations Programme on HIV/AIDS, about 36.7 million people were suffering from HIV in 2015, globally.
Thus, in order to provide proper diagnosis for these diseases and for research regarding effective cures, molecular biology products are increasingly being adopted.